ArticleJournal of personalized medicine2023

Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab.

Camilla Zecchetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.